Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cationic polyamines inhibit anthrax lethal factor protease.

Mark Evan Goldman1, Lynne Cregar, Dominique Nguyen

  • 1Hawaii Biotech, Inc,, 99-193 Aiea Heights Dr,, Aiea, HI 96701, USA. mgoldman@hawaii.edu

BMC Pharmacology
|June 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The texture of resilience: a Darier disease perspective.

The British journal of dermatology·2025
Same author

Informed Consent for Artificial Intelligence in Dermatology: Practicalities and Pitfalls.

The Australasian journal of dermatology·2025
Same author

On the horizon; considerations on convenience of oral biologic agents in psoriasis.

The International journal of pharmacy practice·2025
Same author

The Place of the Full Skin Examination in the Digital Landscape.

The Australasian journal of dermatology·2025
Same author

An Observational Study to Determine the Prevalence of COVID-19 Among Hospitalized Patients With Multidrug-Resistant Enterobacterales Infections and Clinical Outcomes, 10 US Sites, 2020--2022.

Open forum infectious diseases·2025
Same author

Floral phenotypic divergence and genomic insights in an Ophrys orchid: unraveling early speciation processes.

The New phytologist·2024
Same journal

15th Scientific Symposium of the Austrian Pharmacological Society (APHAR).

BMC pharmacology·2014
Same journal

Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio.

BMC pharmacology·2012
Same journal

Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation.

BMC pharmacology·2012
Same journal

The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potency.

BMC pharmacology·2012
Same journal

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.

BMC pharmacology·2012
Same journal

5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.

BMC pharmacology·2012
See all related articles

Researchers discovered that spermine and related polyamines inhibit anthrax lethal factor (LF) protease activity. This finding offers new therapeutic strategies for anthrax infection, targeting bacterial virulence factors.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Anthrax is a serious human disease caused by Bacillus anthracis.
  • Current vaccines and antibiotics have limitations in prophylaxis and treatment.
  • Targeting the lethal factor (LF) protease activity is a crucial unmet need for anthrax therapeutics.

Purpose of the Study:

  • To identify and characterize inhibitors of anthrax lethal factor (LF) protease activity.
  • To explore novel therapeutic strategies against Bacillus anthracis infection.

Main Methods:

  • Utilized a fluorescence-based assay to screen for LF protease inhibitors.
  • Identified and characterized chemically distinct classes of inhibitory molecules.
  • Determined the inhibition constant (Ki) for spermine against anthrax LF.

Related Experiment Videos

Main Results:

  • Identified polyamines, aminoglycosides, and cationic peptides as inhibitors of anthrax LF.
  • Spermine demonstrated significant inhibition of anthrax LF with a Ki of 0.9 +/- 0.09 microM.
  • Linear polyamines showed inhibitory activity, though with lower potency than spermine.

Conclusions:

  • Linear polyamines related to spermine are promising candidates for anthrax therapeutic lead optimization.
  • Further studies in cell-based models are needed to assess compound cell penetration.
  • The influence of nucleic acids on compound potency requires consideration during drug development.